Journal article · 2026 · Open access
Biosimilar Development Considerations for Therapeutic Proteins With Limited Systemic Exposure: A Landscape Analysis and Pathway Evaluation
Clinical Pharmacology & Therapeutics · Published 27 October 2026 · DOI 10.1002/cpt.70543
In brief
“Biosimilar Development Considerations for Therapeutic Proteins With Limited Systemic Exposure: A Landscape Analysis and Pathway Evaluation” is a 2026 journal article by Ting Wang and 5 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 0 citations as of 17 November 2026. It is open access under a public domain licence: the full text is free to read at Clinical Pharmacology & Therapeutics.
- Citations
- 0
- References
- 1
- Authors
- 6
Abstract
Biosimilar development for therapeutic proteins (TPs) with limited systemic exposure presents distinct challenges, as the new paradigm based on comparative analytical assessments plus pharmacokinetic similarity without a comparative efficacy study (CES) is inapplicable. Of 19 TPs with limited systemic exposure, 15 are well-characterized, of which 12 have at least one CES-feasible indication. The remaining 3 may require alternative strategies, including pharmacodynamic (PD) biomarker approaches or optimized CES designs, underscoring the need for proactive regulatory engagement.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Wang, T., Zheng, J., Hsieh, P.-H., Le, A., Wang, Y., & Sun, Q. (2026). Biosimilar Development Considerations for Therapeutic Proteins With Limited Systemic Exposure: A Landscape Analysis and Pathway Evaluation. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70543
MLA 9
Wang, Ting, et al. “Biosimilar Development Considerations for Therapeutic Proteins With Limited Systemic Exposure: A Landscape Analysis and Pathway Evaluation.” Clinical Pharmacology & Therapeutics, 2026. https://doi.org/10.1002/cpt.70543.
Chicago
Wang, Ting, Jenny Zheng, Po-Hung Hsieh, Anh‐Dung Le, Yow‐Ming Wang, and Qin Sun. 2026. “Biosimilar Development Considerations for Therapeutic Proteins With Limited Systemic Exposure: A Landscape Analysis and Pathway Evaluation.” Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70543.
Harvard
Wang, T. et al. (2026) ‘Biosimilar Development Considerations for Therapeutic Proteins With Limited Systemic Exposure: A Landscape Analysis and Pathway Evaluation’, Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.70543.
IEEE
T. Wang, J. Zheng, P.-H. Hsieh, A. Le, Y. Wang, and Q. Sun, “Biosimilar Development Considerations for Therapeutic Proteins With Limited Systemic Exposure: A Landscape Analysis and Pathway Evaluation,” Clinical Pharmacology & Therapeutics, 2026, doi: 10.1002/cpt.70543.
BibTeX
@article{wang2026biosimilar,
title = {{Biosimilar Development Considerations for Therapeutic Proteins With Limited Systemic Exposure: A Landscape Analysis and Pathway Evaluation}},
author = {Wang, Ting and Zheng, Jenny and Hsieh, Po-Hung and Le, Anh‐Dung and Wang, Yow‐Ming and Sun, Qin},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2026},
doi = {10.1002/cpt.70543},
url = {https://doi.org/10.1002/cpt.70543}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
- biosimilar development
- therapeutic proteins
- pharmacokinetic similarity
- pharmacodynamic biomarkers
- regulatory engagement
- landscape analysis
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Wang, T., Zheng, J., Hsieh, P.-H., Le, A., Wang, Y., & Sun, Q. (2026). Biosimilar Development Considerations for Therapeutic Proteins With Limited Systemic Exposure: A Landscape Analysis and Pathway Evaluation. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70543
How many times has this paper been cited?
0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.
Who wrote this paper?
Ting Wang, Jenny Zheng, Po-Hung Hsieh, Anh‐Dung Le, Yow‐Ming Wang, Qin Sun.
What is the DOI of this paper?
10.1002/cpt.70543, permanently at https://doi.org/10.1002/cpt.70543. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.